Literature DB >> 25122801

Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.

Douglas S Reed1, Pamela J Glass2, Russell R Bakken2, James F Barth2, Cathleen M Lind2, Luis da Silva3, Mary Kate Hart2, Jonathan Rayner4, Kim Alterson4, Max Custer4, Jeanne Dudek4, Gary Owens4, Kurt I Kamrud4, Michael D Parker2, Jonathan Smith4.   

Abstract

Alphavirus replicons were evaluated as potential vaccine candidates for Venezuelan equine encephalitis virus (VEEV), western equine encephalitis virus (WEEV), or eastern equine encephalitis virus (EEEV) when given individually or in combination (V/W/E) to mice or cynomolgus macaques. Individual replicon vaccines or the combination V/W/E replicon vaccine elicited strong neutralizing antibodies in mice to their respective alphavirus. Protection from either subcutaneous or aerosol challenge with VEEV, WEEV, or EEEV was demonstrated out to 12 months after vaccination in mice. Individual replicon vaccines or the combination V/W/E replicon vaccine elicited strong neutralizing antibodies in macaques and demonstrated good protection against aerosol challenge with an epizootic VEEV-IAB virus, Trinidad donkey. Similarly, the EEEV replicon and V/W/E combination vaccine elicited neutralizing antibodies against EEEV and protected against aerosol exposure to a North American variety of EEEV. Both the WEEV replicon and combination V/W/E vaccination, however, elicited poor neutralizing antibodies to WEEV in macaques, and the protection conferred was not as strong. These results demonstrate that a combination V/W/E vaccine is possible for protection against aerosol challenge and that cross-interference between the vaccines is minimal. Importance: Three related viruses belonging to the genus Alphavirus cause severe encephalitis in humans: Venezuelan equine encephalitis virus (VEEV), western equine encephalitis virus (WEEV), and eastern equine encephalitis virus (EEEV). Normally transmitted by mosquitoes, these viruses can cause disease when inhaled, so there is concern that these viruses could be used as biological weapons. Prior reports have suggested that vaccines for these three viruses might interfere with one another. We have developed a combined vaccine for Venezuelan equine encephalitis, western equine encephalitis, and eastern equine encephalitis expressing the surface proteins of all three viruses. In this report we demonstrate in both mice and macaques that this combined vaccine is safe, generates a strong immune response, and protects against aerosol challenge with the viruses that cause Venezuelan equine encephalitis, western equine encephalitis, and eastern equine encephalitis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122801      PMCID: PMC4178741          DOI: 10.1128/JVI.01406-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis.

Authors:  Ronald B Reisler; Paul H Gibbs; Denise K Danner; Ellen F Boudreau
Journal:  Vaccine       Date:  2012-09-29       Impact factor: 3.641

2.  Discovery and geographic distribution of Venezuelan encephalitis virus in Guatemala, Honduras, and British Honduras during 1965-68, and its possible movement to Central America and México.

Authors:  W F Scherer; R W Dickerman; J V Ordonez
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

3.  Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.

Authors:  A White; S Berman; J P Lowenthal
Journal:  Appl Microbiol       Date:  1971-11

4.  Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.

Authors:  Douglas S Reed; Matthew G Lackemeyer; Nicole L Garza; Lawrence J Sullivan; Donald K Nichols
Journal:  Microbes Infect       Date:  2011-05-25       Impact factor: 2.700

5.  Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

Authors:  D J McClain; P R Pittman; H H Ramsburg; G O Nelson; C A Rossi; J A Mangiafico; A L Schmaljohn; F J Malinoski
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

6.  Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics.

Authors:  Dipankar Das; Sheryl L Gares; Les P Nagata; Mavanur R Suresh
Journal:  Antiviral Res       Date:  2004-11       Impact factor: 5.970

7.  Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to Eastern or Western Equine encephalitis virus, or both.

Authors:  C H Calisher; D R Sasso; G E Sather
Journal:  Appl Microbiol       Date:  1973-10

8.  Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine.

Authors:  Shannon S Martin; Russell R Bakken; Cathleen M Lind; Douglas S Reed; Jessica L Price; Craig A Koeller; Michael D Parker; Mary Kate Hart; Donald L Fine
Journal:  Vaccine       Date:  2009-09-15       Impact factor: 3.641

9.  A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus.

Authors:  Chad J Roy; A Paige Adams; Eryu Wang; Grace Leal; Robert L Seymour; Satheesh K Sivasubramani; William Mega; Ilya Frolov; Peter J Didier; Scott C Weaver
Journal:  Vaccine       Date:  2013-01-16       Impact factor: 3.641

10.  Isolation of eastern equine encephalitis virus from Aedes albopictus in Florida.

Authors:  C J Mitchell; M L Niebylski; G C Smith; N Karabatsos; D Martin; J P Mutebi; G B Craig; M J Mahler
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

View more
  19 in total

1.  Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Authors:  Farooq Nasar; Demetrius Matassov; Robert L Seymour; Theresa Latham; Rodion V Gorchakov; Rebecca M Nowak; Grace Leal; Stefan Hamm; John H Eldridge; Robert B Tesh; David K Clarke; Scott C Weaver
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Authors:  Jesse H Erasmus; Robert L Seymour; Jason T Kaelber; Dal Y Kim; Grace Leal; Michael B Sherman; Ilya Frolov; Wah Chiu; Scott C Weaver; Farooq Nasar
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.

Authors:  Marcelo M Samsa; Lesley C Dupuy; Clayton W Beard; Carolyn M Six; Connie S Schmaljohn; Peter W Mason; Andrew J Geall; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-01-07       Impact factor: 11.454

4.  Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.

Authors:  Ya-Nan Zhang; Cheng-Lin Deng; Jia-Qi Li; Na Li; Qiu-Yan Zhang; Han-Qing Ye; Zhi-Ming Yuan; Bo Zhang
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

5.  Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus.

Authors:  Henry Ma; Joseph R Albe; Theron Gilliland; Cynthia M McMillen; Christina L Gardner; Devin A Boyles; Emily L Cottle; Matthew D Dunn; Jeneveve D Lundy; Noah Salama; Katherine J O'Malley; Ivona Pandrea; Tobias Teichert; Stacey Barrick; William B Klimstra; Amy L Hartman; Douglas S Reed
Journal:  PLoS Pathog       Date:  2022-06-13       Impact factor: 7.464

Review 6.  Viral and Synthetic RNA Vector Technologies and Applications.

Authors:  Juliane W Schott; Michael Morgan; Melanie Galla; Axel Schambach
Journal:  Mol Ther       Date:  2016-07-05       Impact factor: 11.454

Review 7.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

8.  High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine Development.

Authors:  Ya-Nan Zhang; Zhe-Rui Zhang; Na Li; Xin-Ru Pei; Xiao-Dan Li; Cheng-Lin Deng; Han-Qing Ye; Bo Zhang
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

9.  Complete coding sequences of eastern equine encephalitis virus and venezuelan equine encephalitis virus strains isolated from human cases.

Authors:  Guo-Yun Yu; Michael R Wiley; Jeffrey R Kugelman; Jason T Ladner; Brett F Beitzel; Lori T Eccleston; Elaine M Morazzani; Pamela J Glass; Gustavo F Palacios
Journal:  Genome Announc       Date:  2015-04-23

10.  Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus.

Authors:  Crystal W Burke; Jeffrey W Froude; Sebastian Miethe; Birgit Hülseweh; Michael Hust; Pamela J Glass
Journal:  Viruses       Date:  2018-03-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.